These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9493920)

  • 1. Can we mix behavioral therapy with hypnotics when treating insomniacs?
    Hauri PJ
    Sleep; 1997 Dec; 20(12):1111-8. PubMed ID: 9493920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nighttime versus daytime hypnotic self-administration.
    Roehrs T; Bonahoom A; Pedrosi B; Zorick F; Roth T
    Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxation for insomnia and hypnotic medication use in older women.
    Lichstein KL; Johnson RS
    Psychol Aging; 1993 Mar; 8(1):103-11. PubMed ID: 8461107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia.
    McClusky HY; Milby JB; Switzer PK; Williams V; Wooten V
    Am J Psychiatry; 1991 Jan; 148(1):121-6. PubMed ID: 1888345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients.
    Lomen P; Linet OI
    J Int Med Res; 1976; 4(1):55-8. PubMed ID: 16792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of combined triazolam-behavioral therapy for primary insomnia.
    Milby JB; Williams V; Hall JN; Khuder S; McGill T; Wooten V
    Am J Psychiatry; 1993 Aug; 150(8):1259-60. PubMed ID: 8328575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep restriction therapy and hypnotic withdrawal versus sleep hygiene education in hypnotic using patients with insomnia.
    Taylor DJ; Schmidt-Nowara W; Jessop CA; Ahearn J
    J Clin Sleep Med; 2010 Apr; 6(2):169-75. PubMed ID: 20411695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral treatment of chronic insomnia in psychiatrically ill patients.
    Dashevsky BA; Kramer M
    J Clin Psychiatry; 1998 Dec; 59(12):693-9; quiz 700-1. PubMed ID: 9921709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxation to assist sleep medication withdrawal.
    Lichstein KL; Peterson BA; Riedel BW; Means MK; Epperson MT; Aguillard RN
    Behav Modif; 1999 Jul; 23(3):379-402. PubMed ID: 10467890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of age, performance and hypnotics in the sleep of insomniacs.
    Bonnet MH; Kramer M
    J Am Geriatr Soc; 1981 Nov; 29(11):508-12. PubMed ID: 7299009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of triazolam and chloral hydrate in geriatric insomniacs.
    Piccione P; Zorick F; Lutz T; Grissom T; Kramer M; Roth T
    J Int Med Res; 1980; 8(5):361-7. PubMed ID: 6106611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituting behavioural treatment for drugs in the treatment of insomnia: an exploratory study.
    Espie CA; Lindsay WR; Brooks DN
    J Behav Ther Exp Psychiatry; 1988 Mar; 19(1):51-6. PubMed ID: 3292591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of short-acting hypnotics.
    Mendelson WB; Jain B
    Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and hypnotic treatments for insomnia subtypes.
    Waters WF; Hurry MJ; Binks PG; Carney CE; Lajos LE; Fuller KH; Betz B; Johnson J; Anderson T; Tucci JM
    Behav Sleep Med; 2003; 1(2):81-101. PubMed ID: 15600131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs].
    Stepanski E; Zorick F; Kaffeman M; Sicklesteel J; Roth T
    Nouv Presse Med; 1982 Oct; 11(40):2987-90. PubMed ID: 6128721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a cognitive behavioral self-help program for patients with primary insomnia in general practice - a pilot study.
    Katofsky I; Backhaus J; Junghanns K; Rumpf HJ; Hüppe M; von Eitzen U; Hohagen F
    Sleep Med; 2012 May; 13(5):463-8. PubMed ID: 22342027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy of stimulus control for medicated and nonmedicated insomniacs.
    Riedel B; Lichstein K; Peterson BA; Epperson MT; Means MK; Aguillard RN
    Behav Modif; 1998 Jan; 22(1):3-28. PubMed ID: 9567734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
    Fleming JA; McClure DJ; Mayes C; Phillips R; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():29-37. PubMed ID: 2201728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insomnia therapy and withdrawal of hypnotics].
    Garma L; Widlöcher D; Scherrer J
    Sem Hop; 1982 Nov; 58(42):2441-9. PubMed ID: 6297032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.